Ascentage Pharma Group International

AAPG | NASDAQ

$15.86

+$0.80 (+5.31%)

At close: Sep 21, 2026, 4:00 PM ET

$15.82

-$0.04 (-0.25%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	558.48M	980.65M	221.98M	209.71M	27.91M	12.45M
Cost of Revenue	131.73M	29.09M	30.54M	22M	3.33M	1.97M
Gross Profit	426.75M	951.57M	191.44M	187.71M	24.58M	10.48M
Operating Income	-1.18B	-369.73M	-872.64M	-849.81M	-869.84M	-663.94M
Interest Income	79.89M	37.84M	32.41M	9.73M	7.11M	5.22M
Pretax Income	-1.2B	-395.26M	-932.86M	-887.17M	-832.25M	-675.45M
Net Income	-1.21B	-405.43M	-925.64M	-882.92M	-782.42M	-677.61M
Selling & General & Admin	522.67M	383.12M	376.46M	328.02M	191.26M	64.06M
Research & Development	1.08B	947.25M	706.97M	743.1M	766.49M	564.57M
Other Expenses	6.99	-9.07M	-19.36M	-33.6M	n/a	45.8M
Operating Expenses	1.61B	1.32B	1.06B	1.04B	957.75M	674.43M
Interest Expense	52.6M	64.46M	96.06M	52.79M	16.73M	6.26M
Selling & Marketing Expenses	n/a	196M	195.39M	157.42M	47.75M	1.37M
Cost & Expenses	1.74B	1.35B	1.09B	1.06B	961.08M	676.39M
Income Tax Expense	6.75M	10.43M	-7.15M	-4.25M	-49.83M	2.16M
Shares Outstanding (Basic)	89.03M	75.52M	17.64M	16.48M	15.91M	13.49M
Shares Outstanding (Diluted)	89.03M	75.52M	17.64M	16.48M	15.91M	13.49M
EPS (Basic)	-13.56	-5.36	-52.48	-53.60	-49.12	-50.24
EPS (Diluted)	-13.56	-5.36	-52.48	-53.60	-49.12	-50.24
EBITDA	-1.1B	-237.63M	-743.61M	-786.97M	-798.34M	-652.23M
EBIT	-1.18B	-330.8M	-836.81M	-834.39M	-815.52M	-669.19M
Depreciation & Amortization	84.12M	93.17M	93.2M	47.42M	17.18M	16.97M